This engaging seminar was focused on the evolving role of artificial intelligence (AI) and advanced multi-omics technologies in transforming the liquid biopsy landscape. This event explored how AI is influencing the industry’s trajectory, uncovering new opportunities, and how to enhance the detection and surveillance of cancer.

To read more, click here.